somatotropin (6-13) has been researched along with gliclazide in 1 studies
*Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion. [MeSH]
*Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion. [MeSH]
Studies (somatotropin (6-13)) | Trials (somatotropin (6-13)) | Recent Studies (post-2010) (somatotropin (6-13)) | Studies (gliclazide) | Trials (gliclazide) | Recent Studies (post-2010) (gliclazide) |
---|---|---|---|---|---|
10 | 0 | 0 | 997 | 214 | 308 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ng, FM | 1 |
1 other study(ies) available for somatotropin (6-13) and gliclazide
Article | Year |
---|---|
A comparison of cellular actions between gliclazide and a hypoglycaemic peptide fragment of human growth hormone (hGH 6-13).
Topics: Adipose Tissue; Animals; Blood Glucose; Cells, Cultured; Gliclazide; Glucose Tolerance Test; Growth Hormone; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Male; Peptide Fragments; Rats; Rats, Inbred Strains; Receptor, Insulin; Reference Values; Sulfonylurea Compounds | 1988 |